Comparison of Method for Skin Closure in Colorectal Cancer.
Launched by YOON SUK LEE · Aug 8, 2024
Trial Information
Current as of November 14, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study compares two methods doctors use to close the skin after colorectal cancer surgery: a tissue adhesive glue (skin bond) versus the traditional skin stapler. The main question is which method has a lower rate of surgical site infections within 30 days after surgery. Researchers will also look at secondary questions like how much pain people have after surgery and how the costs of wound care compare between the two methods.
To join, adults aged 19 to 80 who are having planned colorectal surgery and are generally healthy (ASA score 1–2) can be eligible. People with very high medical risk, those over 80, those having other major surgeries, or with uncontrolled diabetes are usually not eligible. Participants will be randomly assigned to receive either skin adhesive or a skin stapler and will be followed for up to about a year to assess infections, pain, recovery, and costs. The study is being done at Seoul St. Mary’s Hospital in Korea and is currently enrolling, with about 304 participants planned. Data from individual patients are not planned to be shared publicly.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • underwent elective colorectal surgery
- • aged 19 to 80 years
- • ASA (American Society of Anesthesiologists) score: 1, 2
- • surgical approach such as laparoscopic or Robotic Xi platform
- Exclusion Criteria:
- • ASA score above 3
- • Aged over 80 years
- • underwent combined surgery for other organ resection
- • uncontrolled DM
About Yoon Suk Lee
Yoon Suk Lee is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic areas, Yoon Suk Lee leads initiatives that prioritize ethical standards, scientific rigor, and regulatory compliance. Through collaboration with leading healthcare professionals and institutions, the sponsor aims to facilitate the development of novel treatments and therapies that address unmet medical needs. Yoon Suk Lee's comprehensive approach to clinical trials emphasizes transparency, patient safety, and data integrity, ensuring that research findings contribute meaningfully to the medical community and enhance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, Seocho, Korea, Republic Of
Patients applied
Trial Officials
Yoon Suk Lee, M.D.,Ph.D
Study Chair
Department of Surgery, Seoul St.Mary's hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported